Hongkai Wang

Hongkai Wang

Auto-generated profile, based on publicly available information

Hongkai Wang

Department of Urology Fudan University Shanghai Cancer Center Shanghai China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2026 in BJU International
Verified
Journal Article
Closed access
XXXiyue Xiao
Xiyue Xiao
XNXudong Ni
Xudong Ni
YZYufan Zhao
Yufan Zhao
XLXiaomeng Li
Xiaomeng Li
SWShanshan Wang
Shanshan Wang
YZYao Zhu
Yao Zhu

14 January 2026 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
TZTing Zhang
Ting Zhang
WGWeiyi Gong
Weiyi Gong
CHCheng Huang
Cheng Huang
HWHongkai Wang
Hongkai Wang
BLBaojun Liu
Baojun Liu
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of uncertain etiology with few specific and effective therapeutic agents approved for its treatment. We examined the underlying processes and the impact of icariin (ICA) on a bleomycin‐induced pulmonary fibrosis model. After giving ICA orally to the experimental mouse model for 4 weeks, the impact of the drug on pulmonary fibrosis was assessed by immunohistochemical analysis, Masson’s trichrome staining, and hematoxylin and eosin staining. 16S rRNA sequencing and 5R 16S rRNA sequencing were applied to investigate the compositions of the gut and lung microbiota, respectively. The alterations of serum metabolites were assessed using untargeted metabolomic technique. ICA treatment attenuated pulmonary fibrosis in the BLM‐induced mouse model. Meanwhile, ICA regulated the abundance and composition of pulmonary along with intestinal microbiota, especially Akkermansia and Lactobacillus . The strong connections between the intestinal and pulmonary microbiota supported the gut–lung axis. In addition, serum metabolic profiles and related metabolic pathways were influenced by ICA intervention. Spearman’s correlation analysis revealed that Akkermansia or Lactobacillus was significantly associated with various metabolites via corresponding metabolic pathways. ICA has a pulmonary‐protective effect against BLM‐induced pulmonary fibrosis, which appears to modulate serum metabolic profiles by affecting the Akkermansia- or Lactobacillus- involved gut–lung axis.